
Bill Wallace
Bill Wallace is Chief Information Officer of Intercept Pharmaceuticals (an Alfasigma subsidiary) and a veteran pharma/biotech IT leader focused on AI adoption.
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
Sep 3, 2026
AI Technologies In Pharma And Biotech: Interview With Bill Wallace - REPLAY
6:56
7:02
7:15
7:26
S
6:44Steve SwanHOST
But the data has got to be as good as perfect, right? And we, you know, we've got to really make sure that before we build out all our models and build out all our technology, right?

Bill WallaceGUEST
So Of course, chat GPT, there's the public part, then there's the more private part.

Bill WallaceGUEST
So this past summer, myself and one of my team members, we were actually messing around with chat GPT because we're interested, right? We're trying to learn things.

Bill WallaceGUEST
So we put in some queries and questions related around our disease space, right? We were not using any of our data.

Bill WallaceGUEST
We were simply going on SatGPT and asking for the information, you know, the free.